Tag Archives: FPM

Faculty conversation: TQT study – this is the end!

Recently, the FDA, other regulatory bodies, and pharmaceutical companies have been exploring options to replace TQTs with preclinical testing or with data collected during standard Phase I trials. Join colleagues from the FPM and also the British Pharmacological Society and … Continue reading

Comments Off on Faculty conversation: TQT study – this is the end!